← Back
$TNGX All transactions

Tango Therapeutics, Inc.

A

$ Value

$0

Shares

10,000

Price

$0

Filed

Jan 6

Insider

Name

Lee Sung

Title

CIK

0001793200

Roles

Director

Transaction Details

Transaction Date

2026-01-02

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

10,000

Footnotes

These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in three substantially equal annual installments following the grant date, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. | This option shall vest and become exercisable in 36 substantially equal monthly installments over a period of three years following the grant date, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Filing Info

Accession No.

0001193125-26-004433

Form Type

4

Issuer CIK

0001819133

Lee Sung's History

Date Ticker Type Value
2026-03-17 CYTK $307K
2026-03-15 CYTK A $0
2026-03-15 CYTK A $0
2026-03-15 CYTK A $0
2026-01-02 TNGX A $0
2026-01-02 TNGX A $0
2025-12-22 CYTK A $0
2025-12-22 CYTK A $0
2025-12-22 CYTK F $50K
2025-12-03 CYTK F $101K

Other Insiders at TNGX (90d)

Insider Bought Sold Last
Beckman Daniella
Chief Financial Officer
$127K 2026-02-03
Weber Barbara
Director, Executive Chair
$374K 2026-02-03
Crystal Adam
President, R&D
$3.0M 2026-04-15